Mark S Hixon

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 4

Top Topics

Sensitive Detection

Clostridium Difficile

Top Venues

Journal of medicinal chemistry

ACS infectious diseases

Journal of the American Chemical Society

Mark S. Hixon Consulting LLC

University of Kansas (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mark S. Hixon Consulting LLC

United States

Principal

Takeda San Diego Inc

United States

Senior Fellow :: Global DMPK

Education History

University of Kansas

United States

PHD :: Medicinal Chemistry

Publications

Steven Blake, Rajani Thanissery, Alissa J Rivera, Mark S Hixon, Mingliang Lin, Casey M Theriot, Kim D Janda
Salicylanilide Analog Minimizes Relapse of Clostridioides difficile Infection in Mice. Journal of medicinal chemistry 63 (13) (2020)
Lauren C Smith, Paul T Bremer, Candy S Hwang, Bin Zhou, Beverly Ellis, Mark S Hixon, Kim D Janda
Monoclonal Antibodies for Combating Synthetic Opioid Intoxication. Journal of the American Chemical Society 141 (26) (2019)
Ryan J Shirey, Daniel Globisch, Lisa M Eubanks, Mark S Hixon, Kim D Janda
Noninvasive Urine Biomarker Lateral Flow Immunoassay for Monitoring Active Onchocerciasis. ACS infectious diseases 4 (10) (2018)
Marion Lanier, Derek C Cole, Yelena Istratiy, Michael G Klein, Phillip A Schwartz, Richard Tjhen, Andy Jennings, Mark S Hixon
Repurposing Suzuki Coupling Reagents as a Directed Fragment Library Targeting Serine Hydrolases and Related Enzymes. Journal of medicinal chemistry 60 (12) (2017)